Position in REGN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$63,330,462
-$30,424,764 QoQ
Shares Held
101,566
-16.3% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#109
of 1,327 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Aberdeen Group plc holds $1,997,986,618 across 85 Biotechnology names. REGN ranks #6 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MANE |
Veradermics, Inc
|
1,096,642 | $134,821,167 | |
| 2 | QURE |
uniQure N.V.
|
2,848,117 | $131,184,269 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,601 | $104,611,833 | |
| 4 | ARGX |
Argenx SE
|
83,822 | $77,767,536 | |
| 5 | ABVX |
Abivax S.A.
|
522,025 | $69,565,051 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
101,566 | $63,330,462 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
646,943 | $61,569,565 | |
| 8 | INSM |
INSMED Inc
|
577,437 | $61,566,331 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $63,330,462 | 101,566 | Shares | Defined | 2026-07-31 | |
| 2026-03-31 | $93,755,226 | 121,344 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $124,840,709 | 161,738 | Shares | Defined | 2026-01-16 | |
| 2025-09-30 | $85,185,590 | 151,503 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $106,968,750 | 203,750 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $155,511,292 | 245,197 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $134,239,299 | 188,451 | Shares | Defined | 2025-01-24 | |
| 2024-09-30 | $196,278,070 | 186,711 | Shares | Defined | 2024-10-25 | |
| 2024-06-30 | $187,311,412 | 178,217 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $211,987,458 | 220,249 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $193,135,969 | 219,900 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $27,721,406 | 33,685 | Shares | Defined | 2023-11-07 | |
| 2023-06-30 | $24,528,079 | 34,136 | Shares | Defined | 2024-06-20 | |
| 2023-03-31 | $27,818,457 | 33,856 | Shares | Defined | 2024-06-20 | |
| 2022-12-31 | $24,059,525 | 33,347 | Shares | Defined | 2024-06-20 | |
| 2022-09-30 | $23,913,431 | 34,714 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $19,092,906 | 32,299 | Shares | Defined | 2022-08-05 | |
| 2022-03-31 | $19,883,317 | 28,469 | Shares | Defined | 2022-05-04 | |
| 2021-12-31 | $22,644,410 | 35,857 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $22,884,275 | 37,814 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $28,879,308 | 51,705 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $35,036,961 | 74,052 | Shares | Defined | 2021-05-06 | |
| 2020-12-31 | $17,344,131 | 35,901 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $18,682,096 | 33,374 | Shares | Defined | 2020-10-21 | |
| 2020-06-30 | $23,618,248 | 37,871 | Shares | Defined | 2020-08-10 | |
| 2020-03-31 | $15,998,332 | 32,764 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||